§7110

8 cases·8 cited

Statute text not available for this section.

8 Citing Cases

84 (DEFRA), Pub. L. No. 98-369, §§ 471, 474(i), 98 Stat. 494, 825– 26, 831–32, the Tax Reform Act of 1986 (TRA 1986), Pub. L. No. 99-514, § 231, 100 Stat. 2085, 2173–80, the Omnibus Budget Reconciliation Act of 1989 (OBRA 1989), Pub. L. No. 101-239, § 7110, 103 Stat. 2106, 2322–26, the Small Business Job Protection Act of 1996 (SBJPA), Pub. L. No. 104-188, § 1204, 110 Stat. 1755, 1773–75, and the Tax Relief and Health Care Act of 2006 (TRHCA), Pub. L. No. 109-432, §§ 104, 123(a), 120 Stat. 2922,

en section 41(a)(1) retained the basic credit calculation supra; however, the credit amount was altered from 25% to 20% ofthe excess ofQRE over "base period research expenses".5 In the Omnibus Budget Reconciliation Act of 1989, Pub. L. No. 101-239, sec. 7110(b), 103 Stat. at 2323-2324, Congress substantially altered the scheme for calculating the research credit, effectivelytying the credit computation to not only research expenditures, but also "gross receipts". As amended and in effect for the

Dharma Enterprises, Petitioner T.C. Memo. 1997-448 · 1997

7110 (West 1990). It is a taxable subchapter C corporation for Federal income tax purposes but has not issued any capital stock. Petitioner's profits are to be used for a common purpose of its members, who do not personally benefit from its profits. Petitioner's articles of incorporation provide that petitioner was formed "to contribute financ

United Therapeutics Corporation v. Commissioner of Internal Revenue 105 F.4th 183 · Cir.